The Journal of Neuroscience, February 27, 2008, 28(9):2212-2220; doi:10.1523/JNEUROSCI.4354-07.2008
Previous Article | Next Article 
Neurobiology of Disease
Neuroaxonal Dystrophy Caused by Group VIA Phospholipase A2 Deficiency in Mice: A Model of Human Neurodegenerative Disease
Koei Shinzawa,1
Hisae Sumi,2
Masahito Ikawa,3
Yosuke Matsuoka,1
Masaru Okabe,3
Saburo Sakoda,2 and
Yoshihide Tsujimoto1
1Department of Medical Genetics, Laboratory of Molecular Genetics and Solution-Oriented Research for Science and Technology, Japan Science and Technology Agency, and 2Department of Neurology, Osaka University Medical School, Osaka 565-0871, Japan, and 3Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
Correspondence should be addressed to Yoshihide Tsujimoto, Laboratory of Molecular Genetics, Osaka University Medical School, Room B8, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Email: tsujimot{at}gene.med.osaka-u.ac.jp
Calcium-independent group VIA phospholipase A2 (iPLA2β) is considered to play a role in signal transduction and maintenance of homeostasis or remodeling of membrane phospholipids. A role of iPLA2β has been suggested in various physiological and pathological processes, including immunity, chemotaxis, and cell death, but the details remain unclear. Accordingly, we investigated mice with targeted disruption of the iPLA2β gene. iPLA2β–/– mice developed normally and grew to maturity, but all showed evidence of severe motor dysfunction, including a hindlimb clasping reflex during tail suspension, abnormal gait, and poor performance in the hanging wire grip test. Neuropathological examination of the nervous system revealed widespread degeneration of axons and/or synapses, accompanied by the presence of numerous spheroids (swollen axons) and vacuoles. These findings provide evidence that impairment of iPLA2β causes neuroaxonal degeneration, and indicate that the iPLA2β–/– mouse is an appropriate animal model of human neurodegenerative diseases associated with mutations of the iPLA2β gene, such as infantile neuroaxonal dystrophy and neurodegeneration with brain iron accumulation.
Key words: phospholipase; neurodegeneration; neuroaxonal dystrophy; knock-out mouse; iPLA2; spheroid
Received Nov. 22, 2006;
revised Jan. 15, 2008;
accepted Jan. 17, 2008.
Correspondence should be addressed to Yoshihide Tsujimoto, Laboratory of Molecular Genetics, Osaka University Medical School, Room B8, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Email: tsujimot{at}gene.med.osaka-u.ac.jp